TheProfitWatch

CYCN - Cyclerion Therapeutics, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.37 0.1 (7.3%) --- --- 0.01 (0.68%) -0.01 (-0.73%) 0.06 (4.26%) -0.01 (-0.71%) -0.05 (-3.55%)

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.11
Diluted EPS:
-0.11
Basic P/E:
-13.3636
Diluted P/E:
-13.3636
RSI(14) 1m:
100.0
VWAP:
1.47
RVol:

Events

Period Kind Movement Occurred At

Related News